UK MHRA completes inspection of Strides unit


Strides Pharma Science Limited (Strides) on Wednesday announced the completion of inspection at its Puducherry facility by the UK Medicines and Healthcare products Regulatory Agency (UK MHRA).

Post the inspection, conducted between 15 and 18 October 2019, the company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection. The Puducherry facility caters to the U.S., other regulated markets and institutional businesses and has capabilities to produce finished dosage formulation products across multiple dosage formats, said a company communique.

R. Ananthanarayanan, MD & CEO, said, “The inspection was conducted a few months after the USFDA inspection that resulted in the warning letter. We stay focused on getting the facility reclassified with the USFDA. We are committed to upholding the highest levels of quality compliance and integrity across all our manufacturing sites.”

You have reached your limit for free articles this month.

To get full access, please subscribe.

Already have an account ? Sign in

Show Less Plan

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Faster pages

Move smoothly between articles as our pages load instantly.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.


A one-stop-shop for seeing the latest updates, and managing your preferences.

Personalised recommendations

A select list of articles that match your interests and tastes.


We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.


Please enter your comment!
Please enter your name here